DLL4 | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

1 April 2025

Compass claims a pivotal win with tovecimig

A biliary tract cancer trial hits on response rate, but survival data will be key.

Subscribe to DLL4